| Literature DB >> 1775772 |
Abstract
Advances in medical treatments have occurred because of the application of new knowledge gained from clinical experiments conducted over the last 250 years. New sources of compounds with anti-tumor activity in human cancer are constantly under investigation. The development of a new drug is a complex process: screening, formulation, production, toxicology studies, FDA approval, and evaluation in phase I, II, and III clinical trials.Entities:
Mesh:
Substances:
Year: 1991 PMID: 1775772 DOI: 10.1016/0749-2081(91)90060-3
Source DB: PubMed Journal: Semin Oncol Nurs ISSN: 0749-2081 Impact factor: 2.315